Business Description
IVERIC bio Inc
NAICS : 325412
SIC : 2834
ISIN : US46583P1021
Description
IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.14 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | -0.43 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -2.7 | |||||
| 3-Year EPS without NRI Growth Rate | -3.3 | |||||
| 3-Year FCF Growth Rate | -5.8 | |||||
| 3-Year Book Growth Rate | 18.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.9 | |||||
| 9-Day RSI | 70.45 | |||||
| 14-Day RSI | 69.88 | |||||
| 6-1 Month Momentum % | 97.51 | |||||
| 12-1 Month Momentum % | 236.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.53 | |||||
| Quick Ratio | 15.53 | |||||
| Cash Ratio | 15.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -40.2 | |||||
| Shareholder Yield % | -1.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -58.74 | |||||
| ROA % | -48.79 | |||||
| ROIC % | -6128 | |||||
| ROC (Joel Greenblatt) % | -10830.04 | |||||
| ROCE % | -53.54 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.49 | |||||
| Price-to-Tangible-Book | 11.48 | |||||
| EV-to-EBIT | -21.87 | |||||
| EV-to-Forward-EBIT | -20.67 | |||||
| EV-to-EBITDA | -21.89 | |||||
| EV-to-Forward-EBITDA | -20.71 | |||||
| EV-to-Forward-Revenue | 405.34 | |||||
| EV-to-FCF | -28.19 | |||||
| Price-to-Net-Current-Asset-Value | 11.55 | |||||
| Price-to-Net-Cash | 11.82 | |||||
| Earnings Yield (Greenblatt) % | -4.57 | |||||
| FCF Yield % | -3.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ISEE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IVERIC bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.76 | ||
| Beta | 0 | ||
| Volatility % | 90.29 | ||
| 14-Day RSI | 69.88 | ||
| 14-Day ATR ($) | 0.479657 | ||
| 20-Day SMA ($) | 39.103 | ||
| 12-1 Month Momentum % | 236.75 | ||
| 52-Week Range ($) | 9.39 - 39.99 | ||
| Shares Outstanding (Mil) | 137.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IVERIC bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IVERIC bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
IVERIC bio Inc Frequently Asked Questions
What is IVERIC bio Inc(ISEE)'s stock price today?
The current price of ISEE is $39.95. The 52 week high of ISEE is $39.99 and 52 week low is $9.39.
When is next earnings date of IVERIC bio Inc(ISEE)?
The next earnings date of IVERIC bio Inc(ISEE) is 2024-05-10 Est..
Does IVERIC bio Inc(ISEE) pay dividends? If so, how much?
IVERIC bio Inc(ISEE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers